1
|
Alborikan S, Von Klemperer K, Bhan A, Walker F, Pandya B, Badiani S, Bhattacharyya S, Petersen S, Lloyd G. Blood biomarkers in patients with repaired Tetralogy of Fallot (rTOF); A systematic review and meta-analysis. International Journal of Cardiology Congenital Heart Disease 2021. [DOI: 10.1016/j.ijcchd.2021.100237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
2
|
Pandya B, Shogan A. 735 An Unusual Case of Cervical Potts Disease in A Pediatric Patient. Br J Surg 2021. [DOI: 10.1093/bjs/znab259.316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Pott’s disease is a form of extrapulmonary tuberculosis (TB) affecting the spine. Approximately 10% of individuals with extrapulmonary TB will have skeletal manifestations with the most common area affected being the spine, followed by the hip and knee. Within the spine, Pott’s disease has a predilection for affecting the thoraco-lumbar region, with the cervical spine being the least affected. Here, we report a case of cervical Pott’s disease in a 16-year-old child, with no risk factors for TB, presenting with neck pain and stiffness. Initial blood results were unremarkable, but a CT scan showed a C5 vertebral body fracture and mild canal stenosis. A sagittal MRI scan demonstrated canal stenosis and a pathologic compression fracture of the C5 vertebrae, a soft tissue mass extending into the epidural and prevertebral spaces and associated cervical cord compression. A trans-oral biopsy confirmed TB and a diagnosis of Pott’s disease. She underwent HALO placement and needed further fusion surgery. She was started on anti-tuberculous therapy and made a good recovery post-operatively.
Collapse
Affiliation(s)
- B Pandya
- Kent and Canterbury Hospital, Canterbury, United Kingdom
| | - A Shogan
- University of Chicago Medicine, Comer Children's Hospital, Chicago, USA
| |
Collapse
|
3
|
Krishnathasan K, Constantine A, Fitzsimmons S, Taliotis D, Bedair R, Curtis S, Frigiola A, Orchard E, Pandya B, Lockhart C, Clift P, Hudsmith L, Oliver J, Papaioannou V, Dimopoulos K. Transition for patients with congenital heart disease in the UK: need for a universal model with adequate training and support. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Adolescence is a vulnerable period for patients with congenital heart disease (CHD). Transition is a process that guides these patients through adolescence and ensures a smooth transfer to adult services, in order improve adherence to medical care and reduce loss to follow-up. While the importance of a formal Transition process is widely recognised and a requirement for specialist services in the UK, the optimal structure and delivery of Transition remains a matter of debate.
Aims
To examine the different models of Transition currently in place in specialist CHD centres around the UK.
Methods
A survey of Adult CHD centres in the UK was performed. A focus was placed on the structure of the Transition service, relevant training and areas of perceived improvement.
Results
There were 10 responses to our survey covering 10 specialist CHD centres. All respondents were consultant adult CHD specialists, looking after patients from the age of 16 [14–17] years. All centres have a specialised Transition service, which runs from the age 13 [11–15] to 18 [16–25] years (duration of transition 5 [2–13] years). The majority of centres (80%) report providing transition care “well before” transfer to adult care, whereas 20% provide transition care at or immediately before transfer (i.e. first adult CHD appointment). Transition is delivered by physicians and clinical specialist nurses in approximately equal numbers in 9 (90%) centres and exclusively by clinical nurse specialists in 1 (10%) centre. A median of 2 [1–5] visits are planned for each patient, with 7 (70%) centres seeing patients at least twice during transition. The majority, but not all centres (70%) provide a health passport during transition. A significant number of centres felt they werer not receiving sufficient support in the following domains: financial (50%), training (30%), clinical space (30%), referrals from paediatrics (50%). All respondents felt that their Transition service had room for improvement. Other areas of improvement highlighted included reduction in loss to follow-up, difficulties in providing a Transition service to patients followed in peripheral hospitals, the need for more support from paediatric services in referring all appropriate patients, and dedicated administrative support. The vast majority of respondents (9, 90%) felt equipped with the appropriate skills to care for transition patients. However, few (2, 20%) had completed formal training in more than one area related to adolescent health and transition.
Conclusions
While all CHD centres have a Transition service, Transition models and delivery differs significantly. There is urgent need for research in this area to develop a unified model, greater financial support and relevant training to optimise care.
Figure 1. Participating UK centres
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- K Krishnathasan
- Royal Brompton Hospital, Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, London, United Kingdom
| | | | - S Fitzsimmons
- University Hospital Southampton NHS Foundation Trust, Congenital Cardiac Service, Southampton, United Kingdom
| | - D Taliotis
- Bristol Heart Institute, Adult Congenital Heart Disease Service, Bristol, United Kingdom
| | - R Bedair
- Bristol Heart Institute, Adult Congenital Heart Disease Service, Bristol, United Kingdom
| | - S Curtis
- Bristol Heart Institute, Adult Congenital Heart Disease Service, Bristol, United Kingdom
| | - A Frigiola
- Guy's & St Thomas' NHS Foundation Trust, Adult Congenital Heart Disease Service, London, United Kingdom
| | - E Orchard
- John Radcliffe Hospital, Department of Cardiology, Oxford, United Kingdom
| | - B Pandya
- Barts Heart Centre, Grown-up Congenital Heart Disease Services, London, United Kingdom
| | - C.J Lockhart
- Royal Victoria Hospital, Department of Adult Congenital Heart Disease, Belfast, United Kingdom
| | - P Clift
- Queen Elizabeth Hospital Birmingham, Department of Cardiology, Birmingham, United Kingdom
| | - L Hudsmith
- Queen Elizabeth Hospital Birmingham, Department of Cardiology, Birmingham, United Kingdom
| | - J Oliver
- Leeds Teaching Hospitals NHS Trust, Department of Adult Congenital Heart Disease, Leeds, United Kingdom
| | - V Papaioannou
- Liverpool Heart and Chest Hospital, Congenital Heart Disease Service, Liverpool, United Kingdom
| | - K Dimopoulos
- Royal Brompton Hospital, Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, London, United Kingdom
| |
Collapse
|
4
|
Sawhney V, Mc Lellan A, Chatha S, Perera D, Aderonke A, Juno S, Whittaker-Axon S, Daw H, Garcia J, Lambiase PD, Cullen S, Bhan A, Von Klemperer K, Walker F, Pandya B, Lowe MD, Ezzat V. Outcome of ACHD patients with non-inducible versus inducible IART undergoing cavo-tricuspid isthmus ablation: the role of empiric ablation. J Interv Card Electrophysiol 2020; 60:49-56. [PMID: 31997041 DOI: 10.1007/s10840-019-00692-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/01/2019] [Accepted: 12/19/2019] [Indexed: 10/25/2022]
Abstract
PURPOSE Catheter ablation for supraventricular tachycardia (SVT) in adults with congenital heart disease (ACHD) is an important therapeutic option. Cavo-tricuspid isthmus (CTI)-dependent intraatrial re-entrant tachycardia (IART) is common. However, induction of sustained tachycardia at the time of ablation is not always possible. We hypothesised that performing an empiric CTI line in case of non-inducibility leads to good outcomes. Long-term outcomes of empiric versus entrained CTI ablation in ACHD patients were examined. METHODS Retrospective, single-centre, case-control study over 7 years. Arrhythmia-free survival after empiric versus entrained CTI ablation was compared. RESULTS Eighty-seven CTI ablations were performed in 85 ACHD patients between 2010 and 2017. The mean age of the cohort was 43 years and 48% were male. Underlying aetiology included ASD (31%), VSD (11.4%), AVSD (9.1%), AVR (4.8%), Fallot's (18.4%), Ebstein's (2.3%), Fontan's palliation (9.2%) and atrial switch (13.8%). CTI-dependent IART was entrained in 59 patients whereas it was non-inducible in 28. The latter had an empiric CTI ablation. Forty-three percent of procedures were performed under general anaesthesia. There were no reported procedural complications. There was no significant difference in the mean procedure or fluoroscopy times between the groups (empiric vs entrained CTI; 169.1 vs 183.3 and 28.1 vs 19.9 min). Arrhythmia-free survival was 64.3% versus 72.8% (p value 0.44) in the empiric and entrained groups at 21 months follow-up. CONCLUSIONS Long-term outcomes after empiric and entrained CTI ablation for IART in ACHD patients are comparable. This is a safe and effective therapeutic option. In the case of non-inducibility of IART, an empiric CTI line should be considered in this cohort.
Collapse
Affiliation(s)
- V Sawhney
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK. .,Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK.
| | - A Mc Lellan
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - S Chatha
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - D Perera
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - A Aderonke
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - S Juno
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - S Whittaker-Axon
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - H Daw
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK.,Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| | - J Garcia
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - P D Lambiase
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK
| | - S Cullen
- Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| | - A Bhan
- Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| | - K Von Klemperer
- Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| | - F Walker
- Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| | - B Pandya
- Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| | - M D Lowe
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK.,Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| | - V Ezzat
- Department of Arrhythmia Services, Barts Heart Centre, St. Bartholomew's Hospital, EC1A 7BE, London, UK.,Grown-up Congenital Heart Disease Services, Barts Heart Centre, St. Bartholomew's Hospital, London, UK
| |
Collapse
|
5
|
Sharma SK, Bharathi P, Prahlad V, Patel PJ, Choksi B, Jana MR, Bansal LK, Qureshi K, Sumod CB, Vadher V, Thakkar D, Gupta LN, Rambabu S, Parmar S, Contractor N, Sahu AK, Pandya B, Sridhar B, Pandya S, Baruah UK. Characteristics of the positive ion source at reduced gas feed. Rev Sci Instrum 2014; 85:113504. [PMID: 25430113 DOI: 10.1063/1.4901596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The neutral beam injector of steady state superconducting tokamak (SST1-NBI) at IPR is designed for injecting upto 1.7 MW of neutral beam (Hº, 30-55 keV) power to the tokamak plasma for heating and current drive. Operations of the positive ion source (PINI or Plug-In-Neutral-Injector) of SST1-NBI were carried out on the NBI test stand. The PINI was operated at reduced gas feed rate of 2-3 Torr l/s, without using the high speed cryo pumps. Experiments were conducted to achieve a stable beam extraction by optimizing operational parameters namely, the arc current (120-300 A), acceleration voltage (16-40 kV), and a suitable control sequence. The beam divergence, power density profiles, and species fractions (H(+):H2(+):H3(+)) were measured by using the diagnostics such as thermal calorimetry, infrared thermography, and Doppler shift spectroscopy. The maximum extracted beam current was about 18 A. A further increase of beam current was found to be limited by the amount of gas feed rate to the ion source.
Collapse
Affiliation(s)
- S K Sharma
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - P Bharathi
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - V Prahlad
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - P J Patel
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - B Choksi
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - M R Jana
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - L K Bansal
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - K Qureshi
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - C B Sumod
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - V Vadher
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - D Thakkar
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - L N Gupta
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - S Rambabu
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - S Parmar
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - N Contractor
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - A K Sahu
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - B Pandya
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - B Sridhar
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - S Pandya
- Institute for Plasma Research, Bhat, Gandhinagar, India
| | - U K Baruah
- Institute for Plasma Research, Bhat, Gandhinagar, India
| |
Collapse
|
6
|
Power A, Duncan N, Pusey C, Usvyat L, Marcelli D, Marelli C, Kotanko P, Li Z, Wang J, Yuan X, Wang J, Wang L, Ozkayar N, Altun B, Yildirim T, Yilmaz R, Dede F, Hayran M, Arici M, Aki T, Erdem Y, Vink EE, Siddiqi L, Verloop WL, van Schelven LJ, Liam Oey P, Blankestijn PJ, Vink EE, Verloop WL, Voslkuil M, Spiering W, Vonken EJ, Blankestijn PJ, Branco PQ, Gaspar AC, Sousa HS, Martins AR, Dores H, Goncalves P, Almeida M, Mendes M, Barata JD, Shi X, Xia P, Wen Y, Jiang L, Li H, Li X, Li X, Chen L, Quiroz YJ, Franco M, Tapia E, Bautista R, Pacheco U, Santamaria J, Johnson RJ, Rodriguez-Iturbe B, Suttorp MM, Hoekstra T, Dekker FW, Lin L, Zhang W, Yang J, He Y, Maciorkowska D, Zbroch E, Koc-Zorawska E, Malyszko JS, Mysliwiec MC, Malyszko J, Sala N, Navarro Diaz M, Serra A, Lopez D, Bonet J, Romero R, Qiu L, Li Y, Chen L, Zhu G, Schiller A, Bob F, Enache A, Jurca-Simina F, Mociar D, Bozdog G, Munteanu M, Petrica L, Velciov S, Bansal V, Timar R, Branco PQ, Gaspar AC, Sousa HS, Martins AR, Goncalves PA, Dores H, Mendes A, Mendes M, Barata JD, Calderon C, Lavilla FJ, Mora JM, Lopez D, Garcia-Fernandez N, Martin PL, Errasti P, David C, Ciocalteu A, Niculae A, Checherita AI, Otowa T, Yasuda T, Uehara K, Kawarazaki H, Shibagaki Y, Kimura K, Hasegawa H, Kanozawa K, Asakura J, Takayanagi K, Tayama Y, Okazaki S, Hara H, Kiba T, Mitani T, Iwanaga M, Ogawa T, Matsuda A, Mitarai T, Yilmaz Z, Yildirim T, Yilmaz R, Aybal-Kutlugun A, Altun B, Kucukozkan T, Erdem Y, Abbss SR, Zhu F, Flores-Gama C, Williams C, Podesta MA, Cartagena C, Carter M, Levin NW, Kotanko P, Gerasimovska Kitanovska B, Bogdanovska S, Severova Andreevska G, Gerasimovska V, Sikole A, Zafirovska K, Boubaker K, Kheder A, Kaaroud H, Lee SM, Park HE, Kim M, Heo NJ, Choi SY, Joo KW, Han JS, Shah S, Pandya B, Schiller A, Munteanu M, Enache A, Bob F, Jurca-Simina F, Mociar D, Timar R, Karanovic S, Fistrek Prlic M, Kos J, Premuzic V, Abramovic Baric M, Matijevic V, Fucek M, Vrdoljak A, Cvitkovic A, Leko N, Bitunjac M, Laganovic M, Jelakovic B, Antlanger M, Kovarik JJ, Domenig O, Kaltenecker C, Hecking M, Haidinger M, Werzowa J, Kopecky C, Heinzl H, Poglitsch M, Saemann MD, Bartmanska M, Wyskida K, Baba M, Tarski M, Adamczak M, Wiecek A, Szotowska M, Fistrek Prlic M, Karanovic S, Pecin I, Laganovic M, Vedran P, Vrdoljak A, Fucek M, Cvitkovic A, Bitunjac M, Abramovic Baric M, Matijevic V, Jelakovic B, Margulis F, Golglid V, Castro C, Ramallo S, Martinez M, Schiavelli R, Demikhova N, Prikhodko O, Vazquez Jimenez LC, Bancu IE, Troya Saborido MI, Bonet Sol J, Tasdemir M, Canpolat N, Caliskan S, Pehlivan G, Sever L, Sasaki K, Kimura T, Sakai S, Iwahashi E, Fujimoto T, Minami S, Oka T, Yokoyama K. Hypertension - human studies. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
7
|
Aigbirhio F, Appleyard MVCL, Arrowsmith RL, Baldwin SA, Bayrakdarian M, Botting NP, Cantin LD, Carbery DR, Carroll MA, Dixon LI, Dorff PN, Ellames G, Elmore CS, Fishwick CWG, Foot O, Geach NJ, Gowdy J, Grainger RS, Gregson T, Harker WRR, Henderson PJF, Heys JR, Homans SW, Hu Z, Jackson S, Johnston J, Johnson P, Kalverda A, Kay C, Kitson SL, Lanoue B, Levitt MH, Li Y, Lockley WJS, Luo X, Ma P, Middleton DA, Newsome J, Pandya B, Pascu SI, Patching SG, Phillips-Jones MK, Powell ME, Riss P, Simmons J, Simpson TM, Smith AD, Thompson AM, Trembleau L, Turtle R, Watters KW, Zhang Q. Abstracts of the 20th International Isotope Society (UK group) Symposium: Synthesis & Applications of Labelled Compounds 2011. J Labelled Comp Radiopharm 2012. [DOI: 10.1002/jlcr.2907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- F. Aigbirhio
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - M. V. C. L. Appleyard
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - R. L. Arrowsmith
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - S. A. Baldwin
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - M. Bayrakdarian
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - N. P. Botting
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - L. D. Cantin
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - D. R. Carbery
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - M. A. Carroll
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - L. I. Dixon
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - P. N. Dorff
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - G. Ellames
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - C. S. Elmore
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - C. W. G. Fishwick
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - O. Foot
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - N. J. Geach
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - J. Gowdy
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - R. S. Grainger
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - T. Gregson
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - W. R. R. Harker
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - P. J. F. Henderson
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - J. R. Heys
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - S. W. Homans
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - Z. Hu
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - S. Jackson
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - J. Johnston
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - P. Johnson
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - A. Kalverda
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - C. Kay
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - S. L. Kitson
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - B. Lanoue
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - M. H. Levitt
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - Y. Li
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - W. J. S. Lockley
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - X Luo
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - P. Ma
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - D. A. Middleton
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - J. Newsome
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - B. Pandya
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - S. I. Pascu
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - S. G. Patching
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - M. K. Phillips-Jones
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - M. E. Powell
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - P. Riss
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - J. Simmons
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - T. M. Simpson
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - A. D. Smith
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - A. M. Thompson
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - L. Trembleau
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - R. Turtle
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - K. W. Watters
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - Q. Zhang
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| |
Collapse
|
8
|
Nair S, Mishra V, Hayden K, Lisboa PJG, Pandya B, Vinjamuri S, Hardy KJ, Wilding JPH. The four-variable modification of diet in renal disease formula underestimates glomerular filtration rate in obese type 2 diabetic individuals with chronic kidney disease. Diabetologia 2011; 54:1304-7. [PMID: 21359581 DOI: 10.1007/s00125-011-2085-9] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/17/2010] [Accepted: 01/17/2011] [Indexed: 11/28/2022]
Abstract
AIMS/HYPOTHESIS GFR is commonly estimated using the four-variable Modification of Diet in Renal Disease (MDRD) formula and this forms the basis for classification of chronic kidney disease (CKD). We investigated the effect of obesity on the estimation of glomerular filtration rate in type 2 diabetic participants with CKD. METHODS We enrolled 111 patients with type 2 diabetes mellitus in different stages of CKD. GFR was measured using (51)Cr-labelled EDTA plasma clearance and was estimated using the four-variable MDRD formula. RESULTS The bias between estimated and measured GFR was -22.4 (-33.8 to -11.0) p < 0.001 in the obese group compared with -6.04 (-17.6 to -5.5) p = 0.299 in the non-obese group. When GFR was indexed to body surface area of 1.73 m(2), the bias remained significant at -9.4 (-13.4 to -5.4) p < 0.001 in the obese participants. CONCLUSIONS/INTERPRETATION This study suggests that the four-variable MDRD formula significantly underestimates GFR in obese type 2 diabetic participants with CKD.
Collapse
Affiliation(s)
- S Nair
- Obesity & Endocrinology Research Unit, Clinical Sciences Centre, University Hospital Aintree, University of Liverpool, Longmoor Lane, Liverpool L9 7AL, UK
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Santos C, Ventura A, Gomes AM, Pereira S, Almeida C, Seabra J, Segelmark M, Mattsson L, Said S, Olde B, Solem K, Yu X, Zhang B, Sun B, Mao H, Xing C, Gruss E, Portoles J, Tato A, Lopez-Sanchez P, Jimenez P, de la Cruz R, Furaz K, Martinez S, Mas M, Andres MM, Corchete E, Kim YO, Kim HG, Kim BS, Song HC, Choi EJ, Ibeas J, Vallespin J, Fortuno JR, Rodriguez-Jornet A, Grau C, Merino J, Branera J, Perendreu J, Granados I, Mateos A, Jimeno V, Moya C, Ramirez J, Falco J, Gimenez A, Garcia M, Morgado E, Pinho A, Guedes A, Guerreiro R, Mendes P, Bexiga I, Silva A, Marques J, Neves P, Shibata K, Iwamoto T, Murakami T, Ono S, Kaneda T, Kuji T, Kawata S, Satta H, Tamura K, Toya Y, Yanagi M, Umemura S, Yasuda G, Yong OL, Lim WWL, Yong KM, Tay KH, Lim EK, Yang WS, Tan SG, Choong HL, Hill A, Blatter D, Kim YO, Kim HG, Song HC, Choi EJ, Kim SY, Min JK, Park WD, Kim HG, Kim YO, Kim BS, Kim SY, Min JK, Park WD, Ibeas J, Fortuno JR, Branera J, Rodriguez- Jornet A, Perendreu J, Marcet M, Vinuesa X, Mateo A, Jimeno V, Fernandez M, Moya C, Rivera J, Falco J, Garcia M, Shibahara H, Shibahara N, Takahashi S, Shibahara H, Shibahara N, Takahashi S, Kanaa M, Wright MJ, Sandoe JAT, Freudiger H, Dupret J, Jacquemoud MC, Rossi L, Kampouris C, Hatzimpaloglou A, Karamouzis M, Pliakos C, Malindretos P, Roudenko I, Grekas D, Costa AC, Santana A, Neves F, Costa AGD, Chaudhry M, Bhola C, Joarder M, Lok C, Coentrao L, Faria B, Frazao J, Pestana M, Sun XF, Yang Y, Wang J, Lin HL, Li JJ, Yao L, Zhao JY, Zhang ZM, Lun LD, Zhang JR, Zhang YM, Li MX, Jiang SM, Wang Y, Zhu HY, Chen XM, Caeiro F, Carvalho D, Cruz J, Ribeiro dos Santos J, Nolasco F, Bartlett R, Pandya B, Viana N, Machado S, Gil C, Lucas C, Mendes A, Barata J, Freitas L, Campos M, Rikker C, Juhasz E, Toth A, Vizi I, Tornoci L, Rosivall L, Tovarosi S, Cho S, Kim S, Lee YJ, Kanai H, Harada K, Nasu S, Shinozaki M, Shibahara N, Shibahara H, Takahashi S, Esenturk M, Zengin M, Ogun F, Akdemir A, Colak C, Pekince G, Gerasimovska V, Oncevski A, Gerasimovska-Kitanovska B, Sikole A, Kiselev N, Chernyshev S, Zlokazov V, Idov E, Bacallao Mendez R, Avila A, Salgado J, Llerena B, Badell A, Aties M, Severn A, Metcalfe W, Traynor J, Boyd J, Kerssens J, Henderson A, Simpson K, Roca-Tey R, Samon S, Ibrik O, Roda E, Gonzalez JC, Viladoms J, Malindretos P, Bamidis P, Liaskos C, Papagiannis A, Vrochides D, Frantzidis C, Sarafidis P, Lasaridis A, Chryssogonidis I, Nikolaidis P, Ibeas J, Vallespin J, Fortuno JR, Merino J, Rodriguez-Jornet A, Branera J, Grau C, Granados I, Mateos A, Jimeno V, Perndreu J, Moya C, Rivera J, Falco J, Gimenez A, Garcia M, Moyses Neto M, Ferreira V, Martinez R, Tercariol CAS, Lima DAFS, Figueiredo JFC, Costa JAC, Alayoud A, Hamzi A, Akhmouch I, Aatif T, Oualim Z, Jankovic A, Ilic M, Damjanovic T, Djuric Z, Popovic J, Adam J, Dimkovic N. Vascular access. Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.39] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
10
|
Pandya B, Ghosh SK, Chude G, Rajmohan MV, Narang R. Retroperitoneal Castleman's disease mimicking soft tissue tumour. Indian J Surg 2007; 69:153-4. [PMID: 23132970 DOI: 10.1007/s12262-007-0009-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2004] [Accepted: 08/27/2007] [Indexed: 11/28/2022] Open
Abstract
Castleman's disease is a type of non-neoplastic lymphoproliferative disease having lymph nodal hyperplasia. It has two distinct microscopic types: hyaline-vascular type and plasma cell type. Clinically, it may present either as a solitary mass, most commonly in the mediastinum, or as a multicentric form whose features are generalized lymph-adenopathy, splenomegaly and involvement of other organs like the lungs and kidneys. Here we report a case of isolated retroperitoneal Castleman's disease, which presented as a lump in the iliac fossa in a young female. A clinico-radio-logical diagnosis of retroperitoneal soft tissue tumour was made and the patient underwent complete surgical excision. The exact diagnosis was only obtained at histopathology and there is no evidence of recurrence at six months follow-up.
Collapse
Affiliation(s)
- B Pandya
- Department of Surgery, M.G.I.M.S. Sewagram, Qrt. No. 5, Vivekanand Block, Wardha, Maharashtra, India 442 102
| | | | | | | | | |
Collapse
|
11
|
Pandya B, Thomson W, Poulton K, Bruce I, Payne D, Qasim F. Azathioprine toxicity and thiopurine methyltransferase genotype in renal transplant patients. Transplant Proc 2002; 34:1642-5. [PMID: 12176518 DOI: 10.1016/s0041-1345(02)02963-9] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- B Pandya
- Renal Unit, MINT, Manchester Royal Infirmary, Manchester, United Kingdom
| | | | | | | | | | | |
Collapse
|
12
|
Pandya B, Anijeet HK, Ahmad R. Metastatic complication of bacteremia in a hemodialysis patient--a diagnostic dilemma. Clin Nephrol 1999; 52:62-3. [PMID: 10442500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/13/2023] Open
|